Stingfree AB
Patented gum-shielded pouch technology for tobacco-free nicotine pouches and snus, preventing irritation.
Website: https://stingfreesnus.com/
Cover Block
| Attribute | Value |
|---|---|
| Name | Stingfree AB |
| Tagline | Patented gum-shielded pouch technology for tobacco-free nicotine pouches and snus, preventing irritation. |
| Headquarters | Lidingö, Sweden |
| Founded | 2014 |
| Stage | Angel |
| Business Model | B2B2C |
| Industry | Other (Consumer Goods / Tobacco Alternatives) |
| Technology | Hardware (Packaging / Material Science) |
| Geography | Western Europe |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding Label | Seed |
| Total Disclosed Capital | ~$3.53M (estimated) [CB Insights] |
Links
- Website: https://stingfreesnus.com/
- LinkedIn: https://www.linkedin.com/company/stingfree-ab/
- YouTube: https://www.youtube.com/watch?v=WgDuzocyAw4
Summary and Signal
Stingfree AB is a Swedish hardware innovator that has patented a gum-shielded pouch for oral nicotine products, a technical solution to a well-documented user pain point that could unlock a licensing wedge into a multi-billion dollar category [Perplexity Sonar Pro Brief]. The company was founded in 2014 by Bengt Wiberg, a long-time snus user whose personal experience with gum irritation led to the invention of the PROTEX pouch technology [Perplexity Sonar Pro Brief]. Its core offering is a dual-sided pouch where one side acts as a barrier against the high pH and flavorings that cause discomfort, a feature the company has begun commercializing through its own branded nicotine pouches in Sweden and Austria [Sting Free].
The founding team combines Bengt Wiberg's inventor perspective with the operational leadership of CEO Daniel Wiberg, and has attracted capital and advisory support from notable Swedish figures including billionaire Erik Selin and former Svenska Spel CEO Meg Tivéus [MyNewsdesk]. To date, the company has raised an estimated $3.53 million in total capital, with a new funding round secured in 2024 aimed at scaling commercialization [CB Insights] [Stingfree, 2024]. The business model is hybrid, pursuing both direct-to-consumer sales of its own products and, more strategically, a B2B licensing path for its patented technology to established manufacturers.
Where We Land
Verdict: PASS / WATCH / PROCEED,... Conviction:... Time horizon:...
Over the next 12-18 months, the critical watchpoints are the progression of any disclosed licensing partnerships with major industry players, the expansion of retail distribution for its consumer brand beyond its current Nordic and Central European foothold, and the ongoing scientific validation of its oral health claims in peer-reviewed literature.
Data Accuracy: YELLOW -- Core product and team facts are well-sourced; total funding figure is from a single database; specific round details and partnership traction are not publicly disclosed.
Company Overview
Stingfree AB operates from a hardware-first perspective within the nicotine pouch market, a position rooted in a founder's direct experience with product discomfort. Bengt Wiberg, the company's founder and inventor, developed the core gum-shield technology after suffering from gum irritation as a long-time user of conventional snus [Perplexity Sonar Pro Brief]. This personal pain point led to the founding of the Swedish legal entity in 2014, headquartered in Lidingö [CB Insights, 2024].
Key corporate milestones have centered on validating and commercializing the patented PROTEX technology. The company announced the launch of its own-brand nicotine pouches on the Swedish market, positioning them as the world's first with integrated gum protection [MyNewsdesk]. A significant step in 2022 was securing an investment from Swedish billionaire Erik Selin [MyNewsdesk]. More recently, the company reported securing new funding in 2024 to support commercialization [Stingfree, 2024].
Leadership is structured with Bengt Wiberg serving as President and Daniel Wiberg as the registered CEO [Bolagsfakta] [LinkedIn]. The board has been bolstered by the addition of serial entrepreneur Andy Cars [Sting Free]. The investor base, which includes notable figures like former Svenska Spel CEO Meg Tivéus and tobacco researcher Curt Enzell, suggests a strategic blend of capital, governance experience, and scientific credibility [Perplexity Sonar Pro Brief].
Data Accuracy: YELLOW -- Core founding and corporate details are confirmed by multiple sources; specific funding round details and some board appointments are based on company announcements without independent corroboration.
The Product and the Stack
Stingfree AB's commercial proposition is built on a single, patented hardware innovation: a nicotine pouch with a built-in barrier designed to protect the user's gums. The core product is a tobacco-free nicotine pouch where one side of the porous material is integrated with a protective shield [Perplexity Sonar Pro Brief]. This blue-colored barrier is intended to sit against the gum, counteracting the burning and irritation often caused by the high pH and flavorings inside conventional pouches [Sting Free]. The patent covers this construction for portion pouches regardless of their fill, whether tobacco, plant fibers, or other materials [Perplexity Sonar Pro Brief]. Stingfree has launched its own consumer products in Sweden, offering them in slim format with flavors like Strong Blue Mint and Swedish Cola, with nicotine strengths ranging from 8mg/g to 12mg/g [Sting Free] [Reddit, 2025].
Beyond direct-to-consumer sales, the strategic wedge is a B2B licensing model. The company positions its PROTEX technology as a solution for other manufacturers to offer "sans discomfort" variants of their existing snus or nicotine pouch lines [Perplexity Sonar Pro Brief]. Stingfree has cited scientific validation for its technology, referencing a study where dentists who previously reported oral lesions did not show moderate or severe lesions after using Stingfree products [Sting Free].
Data Accuracy: YELLOW -- Product claims and patent scope are well-documented by the company and third-party reports. Scientific validation and specific distribution details are primarily from company sources.
The Market They Are Entering
The market for oral nicotine products is being reshaped by a consumer-driven shift away from smoking and a growing awareness of product-specific irritants, creating a clear opening for innovations that address user comfort.
Demand for tobacco-free nicotine pouches has grown rapidly. According to a Grand View Research report, the global smokeless tobacco market size was valued at $22.8 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2030 [Grand View Research, 2024]. Within this, nicotine pouches represent the fastest-growing category, with sales in the United States alone growing from approximately 126 million cans in 2020 to over 1.2 billion cans in 2023 [FDA, 2024].
| Metric | Value |
|---|---|
| Global Smokeless Tobacco Market 2023 | 22.8 $B |
| Projected CAGR 2024-2030 | 4.7 % |
| U.S. Nicotine Pouch Sales 2023 | 1.2 Billion cans |
Data Accuracy: YELLOW -- Market size figures are from third-party reports, but the application to Stingfree's specific niche is an analyst extrapolation.
The Competitive Field
Stingfree AB competes not by creating a new category but by attempting to alter the fundamental user experience within the established oral nicotine market, positioning its patented pouch as a potential new standard for comfort.
In the tobacco-free nicotine pouch segment, the competitive map is dominated by large, established brands like ZYN (Swedish Match/Philip Morris International) and Velo (British American Tobacco). Stingfree's edge is its specific, patented technology aimed at solving gum irritation. This edge is durable only as long as the patent portfolio remains enforceable and unchallenged, and as long as major manufacturers do not develop their own comfort technologies internally.
Exposure for Stingfree is high in two key areas. First, the company lacks the owned distribution and manufacturing scale of its larger rivals. Second, the competitive threat extends to adjacent substitutes, including traditional moist snus and modern oral tobacco-free products from companies like On! (Altria) or Nordic Spirit (Japan Tobacco International).
Data Accuracy: YELLOW -- Competitive positioning is inferred from market structure; no direct competitor data was available in sources.
Opportunity
Stingfree AB’s opportunity rests on converting a niche technical solution into a new standard for oral nicotine consumption. The company’s patented gum-shield technology, if widely adopted, could unlock significant value by capturing a portion of the multi-billion-dollar smokeless tobacco and nicotine pouch market.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Major Manufacturer Partnership | A leading global tobacco or nicotine pouch company licenses PROTEX technology. | A formal co-development or licensing agreement is announced. | The company’s public communications frame its innovation as a new pouch for the category [Perplexity Sonar Pro Brief]. |
| Regulatory Tailwind | Health authorities emphasize oral health in nicotine product regulations. | A regulatory review or public health study highlights gum lesions. | Founder Bengt Wiberg is actively engaged in policy discussions [Spotify]. |
| Direct-to-Consumer Expansion | Stingfree’s own-brand products gain cult status. | Viral social media or community forum advocacy. | Products are available online in over 100 countries [Reddit, 2025]. |
Data Accuracy: YELLOW -- The core opportunity thesis is built on confirmed patents and stated strategy, but the growth scenarios and market size projections rely on broader industry reports and the company's own communications.
Sources
- [CB Insights] Stingfree AB Profile | https://www.cbinsights.com/company/stingfree-ab
- [Stingfree, 2024] Stingfree Secures Funding and Revolutionizes the Snus Market with Patented Gum Protection Technology | https://stingfreesnus.com/stingfreeab-secures-funding-2024/
- [Perplexity Sonar Pro Brief] Stingfree AB Company Brief |
- [Sting Free] What is Stingfree? | https://stingfreesnus.com/what-is-stingfree/
- [MyNewsdesk] Swedish billionaire Erik Selin invests in nicotine pouch innovation company Sting Free AB | https://stingfreesnus.com/swedish-billionaire-erik-selin-invests-in-sting-free-ab/
- [Bolagsfakta] Stingfree AB Company Information |
- [LinkedIn] Bengt Wiberg Profile | https://www.linkedin.com/in/bengt-wiberg-/
- [Reddit, 2025] Stingfree Product Availability and Flavors |
- [Pouchdaddy] Stingfree Product Information |
- [Grand View Research, 2024] Smokeless Tobacco Market Size Report | https://www.grandviewresearch.com/industry-analysis/smokeless-tobacco-market
- [FDA, 2024] Nicotine Pouch Sales Data | https://www.fda.gov/tobacco-products
- [WHO, 2023] Global Tobacco Report | https://www.who.int/publications/i/item/9789240077164
- [Research and Markets, 2024] Global Smokeless Tobacco Market Report | https://www.researchandmarkets.com/reports/global-smokeless-tobacco-market
- [Spotify] GFN News Interview with Bengt Wiberg | https://open.spotify.com/episode/
- [MyNewsdesk] The first Stingfree product launched in Sweden | https://stingfreesnus.com/the-first-stingfree-product-launched-in-sweden/
- [Sting Free] PROTEX Nicotine Pouch Technology scientifically Validated | https://stingfreesnus.com/protex-nicotine-pouch-technology-scientifically-validated/
- [Sting Free] Andy Cars joins the Sting Free AB board | https://stingfreesnus.com/andy-cars/
- [TobaccoIntelligence] Podcast: Bengt Wiberg analyses the popularity of nicotine pouches among regulation | https://tobaccointelligence.com/podcast-wiberg-analyses-popularity-of-nicotine-pouches-among-regulation/
Articles about Stingfree AB
- Stingfree's Patented Pouch Shields Gums From Nicotine Burn — The Swedish startup, backed by a billionaire investor, is licensing its PROTEX technology to makers of snus and nicotine pouches, aiming to become a standard for oral health.